Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25507
Abstract: The value of minimal residual disease (MRD) status by bone marrow and imaging analysis as independent prognostic factors has been well established in multiple myeloma (MM). Nevertheless data about their potential complementarity for a more… read more here.
Keywords: pet; mrd pet; minimal residual; residual disease ... See more keywords
Integration of longitudinal ctdna MRD and PET/CT enhances prognostic stratification in newly diagnosed diffuse large B-cell lymphoma: A prospective multicenter study
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5323
Abstract: Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, with relapse rates of 30–40% despite standard frontline chemoimmunotherapy. Early identification of high-risk patients remains challenging. Circulating tumor DNA (ctDNA) is… read more here.
Keywords: treatment; mrd pet; mrd; ctdna ... See more keywords